Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad
4th March 2026 Uncategorised 0Not long after Novo Nordisk received an untitled letter from the FDA disputing certain elements of the first TV spot for its Wegovy pill, another of the Danish drugmaker’s GLP-1 ads is in the regulator’s crosshairs. More: Novo lands another
read more